Natera, INC Form 4 insider transactions

John Fesko, President and Chief Business Officer of Natera, Inc., sold shares to cover tax obligations following the vesting of restricted stock units.

Matthew Rabinowitz, Executive Chairman of Natera, Inc., sold shares of common stock on March 5, 2024, to cover tax obligations and under a pre-arranged Rule 10b5-1 trading plan.

Jonathan Sheena, co-founder of Natera, Inc., reports the sale of common stock and acquisition of Restricted Stock Units (RSUs) through recent transactions.

Matthew Rabinowitz, Executive Chairman of Natera, Inc., reports the acquisition of 4,104 shares of common stock through the issuance of fully-vested Restricted Stock Units (RSUs).

Daniel Rabinowitz, SEC. AND CHIEF LEGAL OFFICER of Natera, Inc., reports acquiring 2,160 shares of common stock through the issuance of fully-vested Restricted Stock Units (RSUs) on March 1, 2024.

Natera's CEO, Steven Leonard Chapman, reports acquiring 9,326 shares of common stock through fully-vested Restricted Stock Units (RSUs) on March 1, 2024.

Natera's CFO, Michael Brophy, reports acquiring 2,826 shares of common stock through the issuance of fully-vested Restricted Stock Units (RSUs) on March 1, 2024.

Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., reported acquiring 2,329 shares of common stock through the issuance of fully-vested Restricted Stock Units (RSUs) on March 1, 2024.

John Fesko, President and Chief Business Officer of Natera, Inc., reports acquiring 2,400 shares of common stock through the issuance of fully-vested Restricted Stock Units (RSUs).

Daniel Rabinowitz, SEC. AND CHIEF LEGAL OFFICER of Natera, Inc., exercised stock options and sold shares of common stock on February 27 and 29, 2024, according to a Form 4 filing with the SEC.